MAP - Market Access Podcast

Are We Undervaluing the Economic Power of Health, Dr. Malina Müller?

How Should Pharma Respond to the New Reality of Market Access in Germany, Prof. Dr. Thomas Hammerschmidt?

Do Swiss Reimbursement Reforms Open Doors—or Raise New Barriers, Petra Erni?

The Startup Guide to Navigating Healthcare Reimbursement, Featuring Ron de Graaff (Repost)

Europe vs. US: Who Leads the Future of Market Access, Dr. Doug Niven?

What Does It Really Take to Master AMNOG in Today’s Market Access Landscape, Anja Pownell?

Is Cross-Functional Alignment the Secret to Successful Market Access, Kasem Akhras?

How Do You Unlock the Power of Statistics in Market Access, Necdet Gunsoy?

How will AI shape the future of Market Access and Systematic Reviews, Jeffrey Johnson and Kevin Kallmes? (Repost)

How Can Market Access Professionals Plan for Long-Term Success, Adrian Kielhorn?

What Are the Biggest Challenges & Opportunities of JCA, Dr. Nick Leach?

Are We Overlooking the Real Benefits of Medical Innovation, Dr. Ahmed Seddik?

What Are the Biggest Challenges in Implementing AI in Pharma, Jan Kroschinski?

How Can Startups Leverage Market Access to Attract Investors, Johan Olsson?

How Are Data Privacy Laws Delaying Patient Access to New Treatments, Douglas Drake and Adam Skali?

How Can Innovation Planning Transform Market Access Success, Dr. Kasia Hein-Peters?

How does early Market Access bridge the gap between innovation and commercial success, Catherine Bacon?

A Flourishing Career in Pharmaceutical Market Access: Which Skills Are Essential, Dipti Tankala? (Repost)

What happens, when negotiations fail, Prof. Dr. Jürgen Wasem? (Repost)

How can people get equal access to pharmaceuticals, Dr. Nina Lathia? (Repost)

How might digitization change health care in Germany by 2035, Julian Molitor? (Repost)

How to optimize commercialisation of innovative life science products, Dr. Kasia Hein-Peters? (Repost)

What does environmental sustainability mean for Market Access, Gerdi Strydom?

What are the main obstacles in oncology market access, Ed Schoonveld? (Repost)

Is there a place for Real World Evidence in HTA, Dr. Karen Facey? (Repost)

How should market access and medical affairs work together, Dr. Mike Rosenblatt? (Repost)

Summer Special - Webinar: How AI can revolutionize dossier writing, with special guest Aleksey Zavgorodniy

What are the latest trends in Turkish Healthcare Market Access, Oznur Seyhun?

How will AI shape the future of Market Access and Systematic Reviews, Jeffrey Johnson and Kevin Kallmes?

How can Virtual Reality become a game-changer in Healthcare Training, Rodrigo Silva?

How Can AI Unlock the Potential of Market Access, Sandip Shah?

What Does the Future Hold for AI in Healthcare, Aleksey Zavgorodniy?

How to Decode Market Access in Canada: Are There Essential Tips for Success, Tara Cowling and Jody Filkowski?

How has virtual become reality in market access, Glib Kutepov?

What Makes Italy's Healthcare System So Complex, Giacomo Matteo Bruno?

Is Healthcare Just a Business in the US, Aymeric Chaupin?

A Flourishing Career in Pharmaceutical Market Access: Which Skills Are Essential, Dipti Tankala?

Mastering US Market Access: What are proven Strategies for Success, Paul-Lukas Hoffschmidt?

Beyond the CE Mark: How can we achieve Medtech Reimbursement in France, Dr. Benoit Salaun?

Remo Christen – Early paid access in Switzerland – Switzerland, wonderland? (Repost)

How can we overcome the complexity of market access for medical devices in Spain, Sergio Gil?

What is the secret of the cost-efficient healthcare system in Israel, Mirel Stelian? (Repost)

The Startup Guide to Navigating Healthcare Reimbursement, Featuring Ron de Graaff

Navigating the Healthcare Startup Galaxy - key insights with Dr. Thomas Kerscher and Mark Anken.

How to navigate complexities, Aurelie Moser: Market Access in Digital Health vs. Drugs?

AMNOG 2.0 - significant changes for the industry since January 2023, correct - Dr. Flume?

Inside the Swiss decision-makers - how does the system for drugs really work, Dr. Heiner Sandmeier?

How should market access and medical affairs work together, Dr. Mike Rosenblatt?

📠 How will Switzerland make the leap from FAX machines to Digital Healthcare, Dr. Peter Indra?

How does an optimized communication strategy look like, Dr. Arne Näveke?